Best Health Advices

Although in many cases with a normal X-ray test can detect the presence of osteoporosis, is proof of Bone Mineral Density (BMD) that provides definitive information on the existence of the disease.

1. Diagnosis
Despite the availability of accurate diagnosis and effective treatments, many people who are at high risk for osteoporosis are not diagnosed disease. In most European countries is little used test Bone Mineral Density (BMD).

Although a normal X-ray test can detect the presence of osteoporosis, can not yet detect it until at least 30% of bone has been lost and the disease is advanced.

That’s why the only reliable method for assessing the risk of further fractures in a person is the measurement of bone mineral density.

Evidence quick, painless and noninvasive measure BMD. In studies has shown that the relationship between low BMD and the risk of bone fracture is even more pronounced than that between high levels of cholesterol and coronary heart disease, or that between hypertension and seizures.

2. Problems in diagnosis
Among the reasons that influence the practice of low BMD test is the low availability of densitometers, restrictions on the number of staff may perform a scan, the low level of awareness about the usefulness of BMD and in many countries, low or no reimbursement for medical expenses.

However, updating the patient medical data, the search for risk factors, especially the history of fracture, and patient examination are sufficient data to suspect the existence of osteoporosis.

3. Compliance, a core value
In Spain it is estimated there are around two million women have osteoporosis, of which only 300,000 are receiving treatment. While this social situation occurs, science advances at a dizzying pace and offers patients innovative treatments each day, aiming to improve their quality of life.

Faster-acting treatments against the disease, whose effectiveness has been amply demonstrated and allow dosages as simple as a single tablet a week, are or will soon be available to Spanish patients.

However, compliance with treatment, especially when it comes to chronic diseases, remains one of the main workhorses of doctors and patients.

Moreover, the failure stems ineffective treatments. Thus, the dropouts in the treatment involve not only a lower therapeutic efficacy in patients (between 10-25% of hospital admissions due to noncompliance), but also the deterioration of the doctor-patient relationship, lack of improvement and the lack of regular monitoring of the disease.

Possibility Related Posts:

• Beer protects against osteoporosis?
  In the last few days has been tried once again a connection that is passed around a couple of years have been fairly regularly in the daily press....
• Symptoms of Osteoporosis
  Osteoporosis is a disease which often occurs during menopause, the risk of cancer than women in menopause is very large....